The global CO2 medical laser systems market size was valued at USD 500.01 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.00% from 2023 to 2030. The demand for CO2 medical laser systems is increasing due to technological advancements, increasing adoption of laser treatments for aesthetic procedures, high demand for tattoo removal, strategic initiatives by key companies, and rising adoption of laser systems by veterinary care providers. There has been a rise in the prevalence of chronic diseases, such as cancer, urological disorders, stroke, neurovascular diseases, and cardiovascular disorders. According to the WHO, in September 2022, non-communicable diseases were responsible for the death of approximately 40 million people annually worldwide, which is 74% globally.
Factors, such as high blood pressure, obesity, diabetes, and other unhealthy lifestyle-related disorders result in a higher percentage of the population developing non-communicable diseases. The following represents statistical data for the prevalence of various chronic disorders: Cardiovascular Diseases: According to the WHO, in 2021, approximately 17 million people died from these, which is 32% of the global death rate. Furthermore, among these deaths, 85% were caused due to stroke and heart attack. Cost savings & additional benefits to patients, such as improved healthcare, cutting-edge technologies, sophisticated devices, breakthrough medicines, superior hospitality, and individualized care, are some of the major growth drivers.
Medical procedures can prompt people to travel to different countries for better treatment at affordable prices. Cosmetic surgery at a lower cost is an extremely popular choice in medical tourism. According to news article research by CNN health, in February 2019, having surgery abroad saves approximately 40 to 80% of the total cost. The top destinations for individuals seeking cosmetic surgery are Brazil, Japan, Italy, Mexico, Russia, India, Turkey, Germany, and France. According to an article released by SchengenVisaInfo.com, in October 2022, nearly 65,000 foreigners from around 177 different countries, such as Poland, Russia, the Netherlands, South Arabia, and Ukraine, came to Germany to receive medical treatment in 2020.
Furthermore, approximately 1,000 foreigners, mostly from Russia and Ukraine, were treated at University Clinic Freiburg in 2020, which dropped to 800 in 2021. The medical tourism sector has been growing at a significant rate, where individuals are traveling across borders for at least a single night to restore, rejuvenate, or maintain health via medical intervention. According to estimates by India’s Ministry of Tourism, the country witnessed around 186,644 Foreign Tourist Arrivals (FTAs) in 2020 for medical reasons, accounting for total FTAs of 7%. The increasing prevalence of chronic conditions, such as heart disease, cancer, and diabetes, is boosting the demand for CO2 medical laser systems.
For instance, according to the International Diabetes Federation 2021 report, the number of people living with diabetes was approximately 537 million adults (20-79) in 2021 and is expected to reach nearly 783 million by 2045. Similarly, according to the International Society of Aesthetic Plastic Surgery, the number of surgical procedures performed in 2021 in the U.S. was 22.4 million. According to the International Society of Aesthetic Plastic Surgery, in 2021, there were approximately 7,500 plastic surgeons, which is 17.0% of the total number of surgeons in the U.S. These factors are expected to positively impact the market growth during the forecast period.
The dermatology segment held the largest share of more than 21.55% in 2022 of the overall revenue. The segment dominates the market due to increasing demand for esthetic products and treatments. Rising individual awareness, growing adoption of noninvasive & minimally invasive procedures, and increasing demand for esthetic procedures, such as skin rejuvenation, skin tightening, & contouring are anticipated to act as high-impact rendering drivers. In addition, the growing prevalence of various skin conditions, such as dermatitis, acne, psoriasis, moles, skin warts, and lesions, as well as the increasing prevalence of skin cancer—especially in emerging economies—is estimated to boost the CO2 medical laser system market over the coming years. The veterinary segment is expected to exhibit the fastest growth rate during the forecast period.
Laser treatments for pets are a novel rehabilitation technique, used in veterinary medicine for therapeutic and rehabilitation purposes. The primary treatment in use is noninvasive photobiomodulation therapy, in which, a laser beam penetrates the tissue and skin, helping improve the flow of blood. On average, it takes 10 to 14 days for a pet to heal completely post-treatment. Increasing demand for therapeutic lasers, technological advancements, strategic initiatives by key companies, and rising adoption of laser systems by veterinary care providers are some of the key factors propelling the segment growth. According to the American Veterinary Medical Association, the U.S. had about 124,069 veterinary practitioners in 2022. An increase in the number of veterinary hospitals and clinics is likely to further fuel the growth.
The outpatient facilities segment accounted for the maximum share of more than 46.70% in 2022. The increasing investments in R&D and the growing incidence of chronic diseases will drive segment growth. Moreover, the growing need for lasers and their cost-efficient production is anticipated to further drive the segment. In addition, these standalone practices provide special health packages for their employees, thus boosting segment growth. Growth in this segment can mainly be attributed to an increase in the number of specialist clinics performing cosmetic surgeries. Surgical procedures in these clinics are less time-consuming than those in hospitals. Clinics offer treatment or medical care that does not require overnight stays.
Moreover, these clinics are accessible & cost-effective compared to hospitals and offer faster services. Postsurgical monitoring and care are necessary, which is also boosting the demand for dermatology & cosmetics clinics. They provide efficient and effective patient care, maintain a safe environment, and offer an extensive array of services. In addition, the short duration of breast augmentation surgeries performed in these facilities is another key factor contributing to segment growth. A growing number of plastic surgeons are preferring ambulatory implantation surgeries to reduce postsurgical complications and discharge patients with proper pain management. These factors are likely to propel segment growth in the near future.
North America held the largest share of more than 31.10% in 2022. An increase in the number of surgical procedures/hospital visits, the presence of well-established healthcare infrastructure, and favorable reimbursement & regulatory policies in the healthcare industry are among the factors expected to create significant growth opportunities in the market. In addition, the availability of skilled professionals, and high disposable income in developed economies are some of the factors responsible for the large share of North America. Asia Pacific is expected to register the fastest growth rate during the forecast period. A large patient pool and the growing need for technologically improved & cost-effective healthcare solutions are predicted to create considerable growth potential in the region.
As a result of low-cost services and an increase in clinical trials, multinational businesses are making significant R&D investments to tap into emerging markets in the Asia Pacific. These factors will have a significant impact on the region’s growth. A few other factors promoting regional market expansion are improvements in clinical development framework in key nations and a rise in hospital admissions. In addition, it is anticipated that in the coming years, the burden of chronic diseases and the rising geriatric population in the Asia Pacific will drive product demand. The three most prevalent diseases in the region, according to the WHO, were cancer, diabetes, and cardiovascular disorders. However, the regional market expansion could be hampered by a shortage of experienced professionals, a lack of advanced healthcare facilities, and a poor reimbursement environment.
As the demand for CO2 medical laser systems increases, global manufacturers are accelerating their production processes and modernizing them with cost-effective solutions. To support the growing demand for various CO2 medical laser system applications, leading companies are pushing for higher product quality. For instance, in May 2021, Alma Lasers launched Alma PrimeX, a noninvasive platform for skin tightening and body contouring. In addition, in January 2021, Candela announced the launch of the Frax Pro System, featuring dual-depth skin resurfacing using Frax 1550 and Frax 1940 applicators.
In 2022, DEKA M.E.L.A. srl was awarded Best Lasers, Lights, and Energy-based Devices by AGAIN laser at the Aesthetic and Anti-Aging Medicine World Congress (AMWC), held in Monte Carlo. The AGAIN laser is one of the fastest and most powerful platforms in the world for vascular treatments, hair removal, nonablative photorejuvenation, superficial pigmented lesions, and onychomycosis. Some of the prominent players in the global CO2 medical laser systems market include:
LightScalpel
Limmer Laser GmbH
Lumenis Be Ltd. (Boston Scientific Corp.)
Herdeks
Alma Lasers
Bison Medical
DEKA M.E.L.A. srl
UNICORN
Cutting Edge Laser Technologies
IDS
Candela Medical
Cynosure
Lutronic Aesthetic Laser, Visual And Surgical Laser
Aakar Enhancing Life Through Technology
Lynton Laser Ltd.
Cutera
Report Attribute |
Details |
Market size value in 2023 |
USD 548.01 million |
Revenue forecast in 2030 |
USD 1.06 billion |
Growth rate |
CAGR of 10.00% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, end-user, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Norway; Sweden; Denmark; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
LightScalpel, Limmer Laser GmbH; Lumenis Be Ltd. (Boston Scientific Corp.); Herdeks; Alma Lasers;Bison Medical; DEKA M.E.L.A. srl; UNICORN; Cutting Edge Laser Technologies; IDS; Candela Medical; Cynosure;LutronicAesthetic LaserVisual & Surgical Laser; Aakar Enhancing Life Through Technology; Lynton Laser Ltd.; Cutera |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global CO2 medical laser systems market report based on application, end-user, and region:
CO2 Medical Laser Systems Application Outlook (Revenue, USD Million, 2018 - 2030)
Dermatology
Ophthalmology
Gynecology
Urology
Dentistry
Cardiovascular
Veterinary
ENT
Others
CO2 Medical Laser Systems End-user Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Specialty Clinics
Ambulatory Surgical Centers
Research & Manufacturing
Research Institutes
Academic Institutes
CO2 Medical Laser Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global CO2 medical laser systems market size was estimated at USD 500.01 million in 2022 and is expected to reach USD 548.01 million in 2023.
b. The global CO2 medical laser systems market is expected to grow at a compound annual growth rate of 10.00% from 2023 to 2030 to reach USD 1.06 billion by 2030.
b. North America dominated the CO2 medical laser systems market with a share of 31.11% in 2022. An increase in the number of surgical procedures/hospital visits, the presence of well-established healthcare infrastructure, and favorable reimbursement & regulatory policies in the healthcare industry are among the factors expected to create significant growth opportunities in the market
b. Some of the key players operating in the CO2 medical laser systems market include LightScalpel/VetScalpel, Limmer Laser GmbH, Lumenis Be Ltd (Boston Scientific Corporation), Herdeks, Alma Lasers, BISON MEDICAL, DEKA M.E.L.A. srl, UNIONMEDICAL Co., Ltd, Cutting Edge, IDS, Candela Medical, Cynosure, LUTRONIC AESTHETIC LASERS, VISUAL AND SURGICAL LASERS, Aakaar Enhancing life through technology, Lynton Lasers Ltd, Cutera, and others.
b. Key drivers expected to contribute to market growth include rising geriatric population, growing awareness about the safety of these procedures, high unmet medical needs in emerging & low-growth economies, and increasing demand for noninvasive cosmetic surgeries.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."